Page last updated: 2024-08-24

9-(2-phosphonylmethoxyethyl)-2,6-diaminopurine and Uterine Cervical Neoplasms

9-(2-phosphonylmethoxyethyl)-2,6-diaminopurine has been researched along with Uterine Cervical Neoplasms in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Andrei, G; Cannizzaro, C; Cihlar, T; Fiten, P; Frey, CR; Fung, W; Geleziunas, R; Han, B; Hung, M; Liu, X; Opdenakker, G; Snoeck, R; Votruba, I1

Other Studies

1 other study(ies) available for 9-(2-phosphonylmethoxyethyl)-2,6-diaminopurine and Uterine Cervical Neoplasms

ArticleYear
Mutations in adenosine deaminase-like (ADAL) protein confer resistance to the antiproliferative agents N6-cyclopropyl-PMEDAP and GS-9219.
    Anticancer research, 2013, Volume: 33, Issue:5

    Topics: Adenine; Alanine; Amino Acid Sequence; Antineoplastic Agents; Blotting, Western; Drug Resistance, Neoplasm; Female; Humans; Molecular Sequence Data; Mutation; Nucleoside Deaminases; Prodrugs; Protein Conformation; Purines; Sequence Homology, Amino Acid; Tumor Cells, Cultured; Uterine Cervical Neoplasms

2013